208 related articles for article (PubMed ID: 17904555)
1. Activation and inhibition of the proteasome by betulinic acid and its derivatives.
Huang L; Ho P; Chen CH
FEBS Lett; 2007 Oct; 581(25):4955-9. PubMed ID: 17904555
[TBL] [Abstract][Full Text] [Related]
2. New betulinic acid derivatives as potent proteasome inhibitors.
Qian K; Kim SY; Hung HY; Huang L; Chen CH; Lee KH
Bioorg Med Chem Lett; 2011 Oct; 21(19):5944-7. PubMed ID: 21856154
[TBL] [Abstract][Full Text] [Related]
3. Suppression of HIF-1α accumulation by betulinic acid through proteasome activation in hypoxic cervical cancer.
Kim HJ; Cho HS; Ban HS; Nakamura H
Biochem Biophys Res Commun; 2020 Mar; 523(3):726-732. PubMed ID: 31948750
[TBL] [Abstract][Full Text] [Related]
4. Betulinic acid selectively increases protein degradation and enhances prostate cancer-specific apoptosis: possible role for inhibition of deubiquitinase activity.
Reiner T; Parrondo R; de Las Pozas A; Palenzuela D; Perez-Stable C
PLoS One; 2013; 8(2):e56234. PubMed ID: 23424652
[TBL] [Abstract][Full Text] [Related]
5. A potent betulinic acid analogue ascertains an antagonistic mechanism between autophagy and proteasomal degradation pathway in HT-29 cells.
Dutta D; Chakraborty B; Sarkar A; Chowdhury C; Das P
BMC Cancer; 2016 Jan; 16():23. PubMed ID: 26772983
[TBL] [Abstract][Full Text] [Related]
6. Proteasome regulators: activators and inhibitors.
Huang L; Chen CH
Curr Med Chem; 2009; 16(8):931-9. PubMed ID: 19275603
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives.
Huang L; Ho P; Lee KH; Chen CH
Bioorg Med Chem; 2006 Apr; 14(7):2279-89. PubMed ID: 16314103
[TBL] [Abstract][Full Text] [Related]
8. Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells.
Yang H; Landis-Piwowar KR; Lu D; Yuan P; Li L; Reddy GP; Yuan X; Dou QP
J Cell Biochem; 2008 Jan; 103(1):234-44. PubMed ID: 17541980
[TBL] [Abstract][Full Text] [Related]
9. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S
BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel non-covalent inhibitors selective to the β5-subunit of the human 20S proteasome.
Xu K; Wang K; Yang Y; Yan DA; Huang L; Chen CH; Xiao Z
Eur J Med Chem; 2015 Jun; 98():61-8. PubMed ID: 26005024
[TBL] [Abstract][Full Text] [Related]
11. Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1.
Lai W; Huang L; Ho P; Li Z; Montefiori D; Chen CH
Antimicrob Agents Chemother; 2008 Jan; 52(1):128-36. PubMed ID: 17954689
[TBL] [Abstract][Full Text] [Related]
12. Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of sp1 to inhibit lung cancer growth.
Hsu TI; Wang MC; Chen SY; Huang ST; Yeh YM; Su WC; Chang WC; Hung JJ
Mol Pharmacol; 2012 Dec; 82(6):1115-28. PubMed ID: 22956772
[TBL] [Abstract][Full Text] [Related]
13. A 3D QSAR study of betulinic acid derivatives as anti-tumor agents using topomer CoMFA: model building studies and experimental verification.
Ding W; Sun M; Luo S; Xu T; Cao Y; Yan X; Wang Y
Molecules; 2013 Aug; 18(9):10228-41. PubMed ID: 23973995
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of phosphotidylinositol-3 kinase pathway by a novel naphthol derivative of betulinic acid induces cell cycle arrest and apoptosis in cancer cells of different origin.
Majeed R; Hamid A; Sangwan PL; Chinthakindi PK; Koul S; Rayees S; Singh G; Mondhe DM; Mintoo MJ; Singh SK; Rath SK; Saxena AK
Cell Death Dis; 2014 Oct; 5(10):e1459. PubMed ID: 25299784
[TBL] [Abstract][Full Text] [Related]
15. Betulinic Acid and its Derivatives as Potential Antitumor Agents.
Zhang DM; Xu HG; Wang L; Li YJ; Sun PH; Wu XM; Wang GJ; Chen WM; Ye WC
Med Res Rev; 2015 Nov; 35(6):1127-55. PubMed ID: 26032847
[TBL] [Abstract][Full Text] [Related]
16. Betulinic acid and its derivatives as anti-angiogenic agents.
Mukherjee R; Jaggi M; Rajendran P; Siddiqui MJ; Srivastava SK; Vardhan A; Burman AC
Bioorg Med Chem Lett; 2004 May; 14(9):2181-4. PubMed ID: 15081004
[TBL] [Abstract][Full Text] [Related]
17. Anti-AIDS agents--XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives.
Hashimoto F; Kashiwada Y; Cosentino LM; Chen CH; Garrett PE; Lee KH
Bioorg Med Chem; 1997 Dec; 5(12):2133-43. PubMed ID: 9459011
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and proteasome inhibition of lithocholic acid derivatives.
Dang Z; Lin A; Ho P; Soroka D; Lee KH; Huang L; Chen CH
Bioorg Med Chem Lett; 2011 Apr; 21(7):1926-8. PubMed ID: 21388808
[TBL] [Abstract][Full Text] [Related]
19. Cancer preventive agents 9. Betulinic acid derivatives as potent cancer chemopreventive agents.
Nakagawa-Goto K; Yamada K; Taniguchi M; Tokuda H; Lee KH
Bioorg Med Chem Lett; 2009 Jul; 19(13):3378-81. PubMed ID: 19481937
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the divergent activities of betulinic acid via neoglycosylation.
Goff RD; Thorson JS
Org Lett; 2009 Jan; 11(2):461-4. PubMed ID: 19102682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
